Gulf International Bank (Uk) LTD Abbott Laboratories Transaction History

Gulf International Bank (Uk) LTD

$3.96 Billion
Q4 2024

A detailed history of Gulf International Bank (Uk) LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 134,358 shares of ABT stock, worth $17 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

134,358

Previous 135,854 1.1%

Holding current value

$17 Million

Previous $15.5 Million 1.88%

% of portfolio

0.38%

Previous 0.4%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$111.93 - $119.39 $167,447 - $178,607	-1,496 Reduced 1.1%	134,358 $15.2 Million
Q3 2024 Oct 30, 2024	SELL	$100.07 - $118.13 $575,502 - $679,365	-5,751 Reduced 4.06%	135,854 $15.5 Million
Q2 2024 Jul 10, 2024	SELL	$100.73 - $112.44 $1.34 Million - $1.5 Million	-13,324 Reduced 8.6%	141,605 $14.7 Million
Q1 2024 Apr 11, 2024	BUY	$109.52 - $120.96 $652,958 - $721,163	5,962 Added 4.0%	154,929 $17.6 Million
Q4 2023 Jan 11, 2024	SELL	$90.19 - $110.4 $1.45 Million - $1.78 Million	-16,130 Reduced 9.77%	148,967 $16.4 Million
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $1.74 Million - $2.08 Million	-18,181 Reduced 9.92%	165,097 $16 Million
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $5.48 Million - $6.11 Million	-54,388 Reduced 22.88%	183,278 $20 Million
Q1 2023 Apr 12, 2023	SELL	$96.86 - $114.01 $6.21 Million - $7.3 Million	-64,073 Reduced 21.23%	237,666 $24.1 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $138,882 - $162,930	-1,461 Reduced 0.48%	301,739 $33.1 Million
Q3 2022 Oct 07, 2022	BUY	$96.76 - $112.03 $37,252 - $43,131	385 Added 0.13%	303,200 $29.3 Million
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $69,407 - $83,891	680 Added 0.23%	302,815 $32.9 Million
Q1 2022 May 05, 2022	BUY	$114.02 - $139.04 $21,093 - $25,722	185 Added 0.06%	302,135 $35.8 Million
Q4 2021 Jan 24, 2022	SELL	$115.53 - $141.46 $6.83 Million - $8.36 Million	-59,098 Reduced 16.37%	301,950 $42.5 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $602,198 - $666,207	5,162 Added 1.45%	361,048 $42.7 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $133,612 - $157,281	-1,263 Reduced 0.35%	355,886 $41.3 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $4.48 Million - $5.28 Million	-41,143 Reduced 10.33%	357,149 $42.8 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $2.93 Million - $3.2 Million	-27,952 Reduced 6.56%	398,292 $43.6 Million
Q3 2020 Oct 21, 2020	SELL	$91.64 - $111.29 $91,914 - $111,623	-1,003 Reduced 0.23%	426,244 $46.4 Million
Q2 2020 Jul 24, 2020	BUY	$76.57 - $98.0 $290,123 - $371,322	3,789 Added 0.89%	427,247 $39.1 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $42,717 - $62,464	-680 Reduced 0.16%	423,458 $33.4 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $52,601 - $58,558	-670 Reduced 0.16%	424,138 $36.8 Million
Q3 2019 Oct 08, 2019	BUY	$81.84 - $88.74 $61,461 - $66,643	751 Added 0.18%	424,808 $35.5 Million
Q2 2019 Jul 10, 2019	BUY	$72.88 - $85.0 $814,871 - $950,385	11,181 Added 2.71%	424,057 $35.7 Million
Q1 2019 Apr 18, 2019	BUY	$66.22 - $80.06 $94,827 - $114,645	1,432 Added 0.35%	412,876 $33 Million
Q4 2018 Jan 08, 2019	SELL	$65.56 - $74.27 $11.8 Million - $13.4 Million	-180,739 Reduced 30.52%	411,444 $29.8 Million
Q3 2018 Nov 05, 2018	BUY	$60.81 - $73.36 $1.76 Million - $2.12 Million	28,910 Added 5.13%	592,183 $43.4 Million
Q2 2018 Jul 05, 2018	BUY	$57.57 - $63.54 $942,017 - $1.04 Million	16,363 Added 2.99%	563,273 $34.4 Million
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $193,568 - $218,852	-3,440 Reduced 0.63%	546,910 $32.8 Million
Q3 2017 Oct 11, 2017	BUY	$48.06 - $53.64 $26.4 Million - $29.5 Million	550,350	550,350 $29.4 Million

Others Institutions Holding ABT

# of Institutions

3,378

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $221B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.

Account

Gulf International Bank (Uk) LTD Abbott Laboratories Transaction History